Logical Biological
Private Company
Funding information not available
Overview
Founded in 2018, Logical Biological operates as a specialized supplier of human biological materials critical for diagnostics development and quality control. The company differentiates itself through a broad portfolio of disease-focused biospecimens, custom engineering capabilities, and a deep expertise in IVD reagent manufacturing. It functions as a key enabler for diagnostic companies, providing essential raw materials like bulk plasma, clinical swabs, PBMCs, and matched sample sets with comprehensive documentation and ISO 9001-certified quality assurance. Its strategic partnership with Bcell Design for engineered disease-state plasma highlights a move towards higher-value, customized products.
Technology Platform
Dual-platform model: 1) Sourcing and characterization of native human biospecimens (serum, plasma, tissue, etc.) from a global clinical network across multiple disease states. 2) Engineering and customization platform, in partnership with Bcell Design, for creating 'Engineered Disease State Plasma' and other modified raw materials through processes like biomarker spiking, protein purification, pooling, and filtration.
Opportunities
Risk Factors
Competitive Landscape
Logical Biological competes with large commercial biobanks (e.g., BioIVT, Discovery Life Sciences), specialty reagent suppliers, and the internal sourcing departments of major diagnostic companies. It differentiates through a strong focus on IVD manufacturing needs, deep customization capabilities, engineered materials, and a disease-state specialized portfolio rather than general research samples.